Skip to main content

Table 4 Validation of the V1 and V2 vaccine structure through Ramachandran and z-score

From: In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever

Vaccine

Residue covered region

Crude

Refine

V1 vaccine

Residues in most favored regions [A, B, L]

92.40%

94.60%

Residues in additional allowed regions [a, b, l, p]

6.30%

4.00%

Residues in generously allowed regions [~ a, ~ b, ~ l, ~ p]

0.40%

0.00%

Residues in disallowed regions

0.90%

1.30%

z score

 − 3.44

 − 3.73

V2 vaccine

Residues in most favored regions [A, B, L]

87.50%

92.90%

Residues in additional allowed regions [a, b, l, p]

9.50%

6.00%

Residues in generously allowed regions [~ a, ~ b, ~ l, ~ p]

3.00%

0.00%

Residues in disallowed regions

0.00%

1.20%

z score

 − 2.93

 − 2.89